Rémi Gagnon

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Bruce L. Zuraw, William R. Lumry, Douglas Johnston et al. · Journal of Allergy and Clinical Immunology · 2020 · 155 citations · Full text

Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial

Martin Metz, Gordon Sussman, Rémi Gagnon et al. · Nature Medicine · 2021 · 121 citations · Full text

Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

David M. Fleischer, Wayne G. Shreffler, Dianne E. Campbell et al. · Journal of Allergy and Clinical Immunology · 2020 · 95 citations · Full text

Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine

Rémi Gagnon, Marie Noel Primeau, Anne Des Roches et al. · Journal of Allergy and Clinical Immunology · 2010 · 81 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8